Zhejiang Xianju PharmaceuticalLtd Dividends and Buybacks
Dividend criteria checks 5/6
Zhejiang Xianju PharmaceuticalLtd is a dividend paying company with a current yield of 2.5% that is well covered by earnings.
Key information
2.5%
Dividend yield
n/a
Buyback Yield
| Total Shareholder Yield | n/a |
| Future Dividend Yield | 4.5% |
| Dividend Growth | 21.2% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | CN¥0.300 |
| Payout ratio | 48% |
Recent dividend and buyback updates
Recent updates
Zhejiang Xianju PharmaceuticalLtd (SZSE:002332) Seems To Use Debt Quite Sensibly
Oct 16
A Look At The Intrinsic Value Of Zhejiang Xianju Pharmaceutical Co.,Ltd. (SZSE:002332)
Sep 03Zhejiang Xianju PharmaceuticalLtd (SZSE:002332) Will Pay A Dividend Of CN¥0.30
Jun 02Estimating The Fair Value Of Zhejiang Xianju Pharmaceutical Co.,Ltd. (SZSE:002332)
Apr 15There Is A Reason Zhejiang Xianju Pharmaceutical Co.,Ltd.'s (SZSE:002332) Price Is Undemanding
Mar 05Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 002332's dividends per share have been stable in the past 10 years.
Growing Dividend: 002332's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| Zhejiang Xianju PharmaceuticalLtd Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (002332) | 2.5% |
| Market Bottom 25% (CN) | 0.6% |
| Market Top 25% (CN) | 2.2% |
| Industry Average (Pharmaceuticals) | 1.7% |
| Analyst forecast (002332) (up to 3 years) | 4.5% |
Notable Dividend: 002332's dividend (2.5%) is higher than the bottom 25% of dividend payers in the CN market (0.53%).
High Dividend: 002332's dividend (2.5%) is in the top 25% of dividend payers in the CN market (2.08%)
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (47.7%), 002332's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its high cash payout ratio (411.7%), 002332's dividend payments are not well covered by cash flows.